Capsida Biotherapeutics Debuts with $140 Million of Capital

Versant, Westlake Village BioPartners launch next-generation gene therapy company with $50 million Series A Collaboration with AbbVie provides $90 million in up front and equity investment capital to create tissue-targeted gene therapies for three CNS d... Biopharmaceuticals, Venture Capital Capsida Biotherapeutics, AbbVie
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news